Sat Kartar Shopping Ltd

Sat Kartar Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sat Kartar Shopping Ltd

₹ 195 -1.17%
31 Oct - close price
satkartar.in NSE - SME: SATKARTAR
About

Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company that delivers natural wellness solutions for therapeutic and lifestyle products.[1]

Key Points

Business Model[1]
The company operates in the Ayurveda healthcare sector using a Direct-to-Consumer (D2C) model, combining Ayurvedic principles with modern research. It focuses on product innovation, branding, and marketing while outsourcing manufacturing to trusted partners, adopting an asset-light strategy.

Website NSE - SM
  • Market Cap ₹ 307 Cr.
  • Current Price ₹ 195
  • High / Low ₹ 242 / 130
  • Stock P/E 22.3
  • Book Value ₹ 37.0
  • Dividend Yield 0.36 %
  • ROCE 39.7 %
  • ROE 32.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 47.6%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2024 Sep 2024 Mar 2025 Sep 2025
75 76 87 88
69 70 79 78
Operating Profit 6 6 9 10
OPM % 8% 7% 10% 12%
0 0 1 2
Interest 0 0 0 0
Depreciation 1 1 1 1
Profit before tax 5 5 8 11
Tax % 27% 25% 25% 26%
4 4 6 8
EPS in Rs 13.29 3.30 3.80 4.95
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
52 83 128 163 175
49 78 118 149 157
Operating Profit 3 5 10 14 19
OPM % 5% 6% 8% 9% 11%
0 0 0 1 2
Interest 0 0 1 1 1
Depreciation 1 1 1 1 2
Profit before tax 2 3 9 13 19
Tax % 7% 27% 27% 25%
1 3 6 10 14
EPS in Rs 1.99 3.59 22.54 6.24 8.75
Dividend Payout % 0% 0% 3% 11%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 46%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 90%
TTM: 83%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 48%
Last Year: 32%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.70 0.70 3 16 16
Reserves 0 3 7 36 42
8 4 2 6 2
3 8 11 6 11
Total Liabilities 12 15 22 64 71
5 4 8 7 6
CWIP 0 0 0 0 1
Investments 0 0 0 0 1
8 11 14 57 63
Total Assets 12 15 22 64 71

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025
7 -5
-3 -0
-3 34
Net Cash Flow 2 28

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 1 0 7 13
Inventory Days 31 25 23 185
Days Payable 165 226 237 170
Cash Conversion Cycle -134 -200 -208 29
Working Capital Days 1 -14 -7 31
ROCE % 50% 98% 40%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2025Sep 2025
63.34% 63.43%
6.31% 0.44%
3.70% 3.10%
26.65% 33.03%
No. of Shareholders 425717

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls